MS Cares – Cumberland, MD

Western Maryland Health System 12500 Willowbrook Rd, Cumberland, MD, United States

This case-based live activity will cover the treatment and management of patients with multiple sclerosis (MS).

Gastric Cancer 3D – Joliet, IL

Presence St. Joseph's Medical Center 333 N. Madison St., Joliet, IL, United States

This live activity will cover the treatment and management of patients with advanced gastric cancer (GC) and gastroesophageal junction cancer.

Prostate Cancer – San Antonio, TX

UT Health Mays Cancer Center 7979 Wurzbach Rd., San Antonio, TX, United States

This CME initiative is designed to meet the educational needs of urologists, medical oncologists, oncology nurses, and other health care providers involved in the treatment of patients with prostate cancer.

Breast Tumor – North Hills, CA

West LA VAMC (Sepulveda) 16111 Plummer Street, North Hills, CA, United States

This live activity will cover the treatment and management of patients with metastatic, hormone receptor-positive, HER-2 negative breast cancer.

Bladder Cancer – Chicago, IL

Saint Anthony Hospital 2875 W 19th Street, Chicago, IL, United States

This live activity will cover the treatment and management of patients with bladder cancer.

Gastric Cancer 3D – Decatur, TX

Wise Health System - East Campus 609 Medical Center Drive, Decatur, TX, United States

This live activity will cover the treatment and management of patients with advanced gastric cancer (GC) and gastroesophageal junction cancer.

Bladder Cancer – Richmond, VA

Virginia Commonwealth University (VCU) Massey Cancer Center 401 College Street, Richmond, VA, United States

This live activity will cover the treatment and management of patients with bladder cancer.

Follicular Lymphoma – Santa Fe, NM

CHRISTUS St. Vincent Regional Medical Center 455 St. Michael's Dr. Suite 1711B, Santa Fe, NM, United States

This live activity will review newly approved and investigational agents and combinations of agents that may improve outcomes for patients with relapsed, refractory follicular lymphoma (FL). Traditionally, FL has been associated with the development of aggressive disease and poor outcomes for many patients. The ongoing development of new compounds with unique mechanisms of action extends the available treatment options for patients across all lines of therapy, with an emphasis on personalization of care.

Breast Tumor – Prescott, AZ

Northern Arizona VAHCS 500 N Hwy 89, Prescott, AZ, United States

This live activity will cover the treatment and management of patients with metastatic, hormone receptor-positive, HER-2 negative breast cancer.

Prostate Cancer – San Antonio, TX

UT Health Mays Cancer Center 7979 Wurzbach Rd., San Antonio, TX, United States

This CME initiative is designed to meet the educational needs of urologists, medical oncologists, oncology nurses, and other health care providers involved in the treatment of patients with prostate cancer.

Gastric Cancer 3D – Clarksburg, WV

Louis A Johnson VAMC Clarksburg, WV, United States

This live activity will cover the treatment and management of patients with advanced gastric cancer (GC) and gastroesophageal junction cancer.

Follicular Lymphoma – Philadelphia, PA

Cancer Treatment Centers of America 1331 E. Wyoming Ave, Philadelphia, PA, United States

This live activity will review newly approved and investigational agents and combinations of agents that may improve outcomes for patients with relapsed, refractory follicular lymphoma (FL). Traditionally, FL has been associated with the development of aggressive disease and poor outcomes for many patients. The ongoing development of new compounds with unique mechanisms of action extends the available treatment options for patients across all lines of therapy, with an emphasis on personalization of care.